chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a physician refers to a female patient of unknown age. Patient's concurrent condition included anxiety. Her relevant medical history and drug reactions/allergies were not reported. On 06-MAY-2015 and 07-JUL-2015, the patient was vaccinated with first and second dose of GARDASIL (lot # L007531, expiry date: not provided and lot # L009964, expiry date: not provided) respectively, intramuscular for prophylaxis (reported as HPV vaccination). Concomitant therapies included ZOLOFT. Reporting physician stated that the patient experienced dizziness and felt like jelly everywhere in her body except in her feet, on an unspecified date in July 2015 (reported as about a week) after receiving both her first and second doses of GARDASIL. Patient sought medical attention and visited the physician on an unspecified date. Reporting physician stated that the patient could not clarify about her experience of feeling like jelly everywhere in her body except in her feet, but physician thought this could mean numbness. No treatment was given for the adverse events. Outcome of the events, hypoaesthesia and dizziness was reported as not recovered. Reporting physician did not assessed the causality of the events with respect to vaccination with GARDASIL. Additional information has been requested.
Fever 101.0, chills, headache severe, joint pain, muscle pain, vomiting, nausea, fatigue. Treated with ale e Advil and bed rest.
Pfizer monovalent covid vaccine was given instead of Pfizer bivalent covid vaccine.
This spontaneous case, initially received from the other non-health care professional (patient) on 30-Jan-2018, concerns 62-year-old, adult, female patient. The patient's current condition included hypertension (since an unspecified date). The patient's concomitant medications included losartan, Propranolol for hypertension and Multivitamins for unknown indications. On 24-Jan-2018, the patient was administered with AFLURIA QUADRIVALENT (dose:0.5ml, route of administration: intramuscular, anatomical location: left deltoid, batch number; XF32808 and expiry date: 30-Jun-2018). On 26-Jan-2018, after 2 days of vaccination, the patient developed pain in the upper thighs and lower quads of both legs, headache and vomiting. It was reported that, the patient's walk was slow and could not walk and she was unable to walk on the stairs. The patient was scared and applied ice on her legs and done salt baths. The patient stated that, the pain lasted for 4 days. On an unspecified date, the patient had recovered from the events difficulty in walking, headache, nausea, scary and pain in legs. The reporter assessed this case as non-serious. Follow-up received from the other non-health care professional (patient) on 01-Mar-2018: The patient confirmed that, she had no other medical history except hypertension (current condition). It was reported that the patient had recovered from the event pain in legs and was able to walk again. Narrative was amended accordingly. Significant case correction received with IRD 30-Jan-2018: Verbatim for the event 'gait disturbance' was changed from couldn't walk my stairs to could not walk my stairs. LLT was changed for the event pain in extremity from pain in legs to pain in extremity, as pain occurred in both thighs and legs. Amended narrative accordingly. Non-significant case correction received with IRD 30-Jan-2018: The verbatim for the event, nausea was corrected from 'She developed [headache and nausea] after receiving the vaccine' to 'She developed [headache and] and nausea after receiving the vaccine'. No changes were made in narrative.
(This HPI is from an Infectious Disease consult):  Patient is a 16 yo female with no significant past medical history that was referred to clinic to discuss COVID19 vaccination. The mother reports that she believes in vaccines and everyone else in the house has gotten the primary COVID19 series, however, she feels hesitant with giving Patient the second dose because of possible adverse effects from dose #1. Patient had acute SARS-CoV2 infection in September 2021 and recovered well, she had URI symptoms x 5 days, mild myalgias and fevers x 2 days. Otherwise no other issues. In 11/14. Patient had her first dose of the vaccine. A bout 14 hours after she received the vaccine, she was sitting in class in started to feel numbness and tingling in and all of her extremities. The tingling started to spread and she also felt she was unable to walk or move her hands. She was brought to the ED where  Patient also felts that she couldn't breath. She was placed on oxygen and she also felt that her face was numb. No rash or itching. She is tachycardic in the 120s and then about 4 hours later she developed a fever.  After her fever came down her symptoms seem to improve.  Over the next few days she felt a little bit achy and a little tired, but her symptoms have completely resolved.  She had labs that were unremarkable, and a normal EKG in the ER.  Mom has been extensively counseled by her PCP but mom wanted to discuss further with ID.  Mom looked up the symptoms online and was concerned that Patient may have developed Guillain-Barre syndrome and is very worried that dose #2 would be worse.  Patient and mom would very much like the second dose so she can travel, they just want to make sure it is safe. Pmhx Non significant pmhx. no anxiety, no panic attacks, no hosp or surg. Social hx lives with both parents and sibs. Family Hx: no hx of adverse reactions to any vaccines. No hx of autoimmune disorders. No hx of severe allergies.
Developed shortness of breath, chest tightness and cough in addition to severe fatigue, sore throat, joint/muscle pain, nausea and abdominal discomfort with diarrhea.  Fatigue, fever, joint/muscle pain began the next day.  Shortness of breath, chest tightness, cough and sore throat started on the second day after receiving the vaccine.  Fever resolved by day 3.  Shortness of breath, chest tightness, sore throat and cough resolved on the 6th day.  Fatigue, muscle/joint pain resolved by day 7.  Developed nasal congestion by day 5 which resolved on day 10.   Treatment was rest, fluids, Tylenol,  and Claritin.
My daughter had bleeding after needle was injected and removed.  I am concerned the vaccine was given intravenously, and I am not sure how to proceed.
Injection site rash & discomfort with some regional spread and headache - x 5 days,
Morning following vaccine had sour stomach and did not take medications. Did not prevent me from having normal day. 2200 began to have chills, checked temperature it was 100.4 and took 2 ibuprofen and went to bed. Woke up at 00:30 with fever of 102.7 and took 1000 mg acetaminophen. Restless night of sleep, waking up very thirsty, felt terrible. Alarm at 06:45 with no fever and felt tired but not bad. Went to work and felt fatigued but able to perform job. No further adverse events.
Tenderness and soreness in armpit; Tenderness and soreness in armpit; Enlarged lymph nods in left arm near on side of injection site; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 09Jul2021 at 01:15 (at the age of 55-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included hydrochlorothiazide, losartan (HYDROCHLOROTHIAZIDE;LOSARTAN) for unspecified indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 14Jul2021 at 11:00 (at the age of 55-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Jul2021 at 16:00, the patient experienced tenderness and soreness in armpit and enlarged lymph nodes in left arm near on side of injection site which had started hours after injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tenderness and soreness in armpit, enlarged lymph nodes in left arm near on side of injection site was not recovered at the time of this report.
2 1/2wk p/vax woke up w/bilat joint stiffness throughout body; 3 1/2 wk p/ c/o paresthesia in the lower extremities & buttock;the week of 28OCT had parasthesia of facial cheeks, ears feeling shaky inside & weak up ambulation;
immediately following vax pt noted small local redness, then pt devel fever & increasing redness of right arm over next few days; in hosp still
Severe hives/rash gradually developed over my body. Starting in my groin area, under my breasts, under my belly fat, on my scalp, on my back Started on March 5 and still going on today March 8!
Patient is a 80 y.o. y.o. female presenting with vomiting.  Fell one week ago with bruise on forehead.  Fell twice on weekend without injury.  4 days ago had 2nd covid booster.  Did not have vomiting side effect with prior shots.  2 days ago started vomiting continuously.  Initially food then yellow bile.  Has been unable to take meds for 2 days including diltiazem and eliquis.  Husband had bronchitis a couple of weeks ago but no GI illness.  Ate the same food as husband.  She does take an H2 blocker for stomach acid.  Has had 7 BMs in same time period but doesn't think they have been loose.  At 1030pm had last vomit and BM episode.  Felt burning chest pain after she vomited, radiated sharply to back, better now.  Called 911 for fast heartrate.  Had HR 150s-180s by paramedics.  SBP 70s.  Tried to cardiovert her twice without success.  In ER finishing 2nd liter bolus with SBP 70s on diltiazem 2.5mg/hour infusion.
Information has been received from a registered nurse concerning a 21  year old female with no pertinent medical history and no drug reactions or allergies who on 29-JAN-2007 was vaccinated intramuscularly with a 0.5 mL dose of HPV (Lot unspecified by reporter). There was no concomitant medication. On 29-JAN-2007 the patient fainted while walking to the waiting room. The patient hit her head on the floor and suffered a concussion. The patient was rushed to an emergency room in an ambulance. She was release later that day. At the time of the report, the patient had recovered. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 3/14/2007. Initial and follow-up information has been received from a licensed practical nurse concerning a 21 year old female, whose repported weight was 176 pounds and whose reported height was 65 inches with no pertinent medical history and no illness at the time of vaccination and no drug reactions or allergies who on 29-JAN-2007, at approximately 12:45 P.M., was vaccinated intramuscularly, into the deltoid muscle with the first 0.5 mL dose of GARDASIL vaccine (Lot #654702/0011U). There was no concomitant medication. It was reported that after the vaccination at 12:55 P.M. (also reported as 1:10 P.M.), the patient proceeded to feel dizzy (also reported as "faint") resulting in the patient "passing out" and reported as fainting while walking to the waiting room. The patient hit her head on scale, which was on the floor. The patient was rushed to an emergency roon in an ambulance and was diagnosed with concussion. She was released later that day. At the time of the report, the patient had recovered. Additional information has been requested.
Pt had a diffuse maculopapular rash, starting in extremities and moving centrally with a low-grade temperature. No oral lesions, conjunctivitis or nasal discharge. Pt was seen on 9/18/01. Her brother got an MMR on the same date. (I also saw another 2 kids with exactly the same rash, 2 days after their immunizations).
Per OSDH: Regarding The VSIR for GSP Health on the following COVID Vaccine Moderna. Please see the following determination; Doses Administered from 4.6.2021 to 5.21.2021:Based on the information you have provided and the lack of temperature data, we are not able to conduct an analysis or guarantee the doses administered between 4/6/2021 and 5/21/2021 provided the necessary protection against a COVID-19 infection. Please continue with the original plan of action on revaccination and completing a VAERS Reports on the all clients you have identified.
I started having shortness of breath, sitting or walking. I went to see my doctor because I thought I had Covid. They did the test and it was negative. It continued for the next week. I went to urgent care and told them about my symptoms. They prescribed me a Zpack and an inhaler. I just used the inhaler because I did not feel sick. I started to get chest pain a few days later. I started to get real bad chest pain so I went to emergency room. They only prescribed an inhaler. They did blood work and an x-ray, which came back normal. I still have shortness of breath.
diagnosed with covid-19; This spontaneous case was reported by a nurse and describes the occurrence of SARS-COV-2 TEST POSITIVE (diagnosed with covid-19) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (diagnosed with covid-19). At the time of the report, SARS-COV-2 TEST POSITIVE (diagnosed with covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was noted that the patient was not using any concomitant medications at the time of the event.   The patient did not receive any treatment for the event. The patient completed their quarantine period on 12Mar2021.
Information has been received from a Doctor of Pharmacy concerning an unspecified number of pts in a retirement community, who were vaccinated with a 2nd dose of pneumococcal vaccine 23 polyvalent and subsequently, the pts experienced "serious reactions". No further information is available.
Felt fine the same day.  The next day:. Shoulder SEVERELY swollen with HUGE bump in and around lymph node, reddened, swelling, heat at inj. site, turned pink then purple then dark purple, throbbing in neck and head, severe headache plus migraine,  difficulty hearing, could not move arm/wrist/fingers/hand, unable to hold fork etc. This lasted for 10 days after onset.
shoulder and upper armed swelled to 1.5 the normal size. large red circle around the injection site with about a 1.5'' diameter. was hard and very warm to the touch. child also complained it was  painful and itchy
Eight days following first shot, my arm started itching near the injection location and two quarter sized red spots showed up. This lasted a few days. 2nd shot was Mar 18 at 11 am at same facility. Had severe arm and shoulder blade pain the remainder of the day. Used an ice pack. Mar 19 had slight fever in the morning. Severe arm pain had resolved. Severe achiness in lower back and jaws and general achiness. Started taking Tylenol in afternoon. Vomited at 6pm and 10:30pm.  Mar 19-21: Severe headache. Barely ate Mar 19-20. Stayed in bed or resting on couch. Experienced intermittent hiccups. No energy. Headache resolved. Mar 22. Mar 26. Still don't feel 100% normal energy level, but pretty much resolved
24 hours after receiving MENVEO vaccine, left arm began to turn red and inflamed. 48 hours, even after BENADRYL and cool compress, area was larger, hot to touch, red and swollen.
fever; breast pain; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of fever in a 28-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number H242K, expiry date 09-JUN-2025) for prophylaxis.   On 16-MAR-2023, the patient received Boostrix (intramuscular, unknown arm) .5 ml. On 16-MAR-2023, less than a day after receiving Boostrix, the patient experienced fever (Verbatim: fever) and breast pain (Verbatim: breast pain). The outcome of the fever and breast pain were not resolved.   It was unknown if the reporter considered the fever and breast pain to be related to Boostrix and Boostrix Pre-Filled Syringe Device.     It was unknown if the company considered the fever and breast pain to be related to Boostrix and Boostrix Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 23-MAR-2023 A pharmacist reported that a patient received Boostrix one week ago and that day she developed a fever and breast pain.  The reporter consented to follow up.  The Vaccine Administration Facility was the same as Primary Reporter.
The patient developed a round rash that is warm to the touch about 3 inches from the injection site  (lower and to the front of the arm) . The rash is getting a bit larger during the day and he will see his doctor tomorrow if still not improving.
I was unable to move from a sitting position without severe pain on my left side and groin; my left knee was locking up; did have a degree of osteoarthritis/after the vaccine it was exacerbated; left in a lot of pain in my knees and hip; This is a spontaneous report from a contactable consumer (patient). A 60-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EWO202, Expiration date: Not reported), via an unspecified route of administration in right arm on 03Jun2021 at 12:00 (at the age of 60-years-old) as dose 2, single for COVID-19 immunization in a hospital. Medical history included osteoarthritis. The patient was allergic to penicillin and shell fish. Concomitant medications/other medications received by the patient in two weeks included duloxetine; pantoprazole and eletriptan hydrobromide (RELPAX). Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EWO175, Expiration date: Not reported), via an unspecified route of administration in left arm on 12May2021 at 15:00 (at the age of 60-years-old) as dose 1, single for COVID-19 immunization. The patient was not pregnant at the time of vaccination and didn't receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Three days after her second shot on 05Jun2021, the patient was unable to move from a sitting position without severe pain on her left side and groin and also her left knee was locking up. The patient did have a degree of osteoarthritis. However, she felt that after the vaccine it was exacerbated where she was currently left in a lot of pain in her knees and hip. The patient received treatment with a steroid shot to the hip and had a series of five gel shots for the events which resulted in doctor or other healthcare professional office/clinic visit and disability or permanent damage. Post-vaccination, the patient was tested for COVID-19 by nasal swab method in 2021 with the negative result. The outcome of these events was not recovered at the time of report.   No follow-up attempts are possible. No further information is expected.
Shortly after administration of the vaccine, the patient's mother reported the patient had a headache, felt tired, was pale, and both eyes were blurry. The protocol under "Treatment of Severe Adverse Events Following Immunization Protocol" was followed and the patient was instructed to lie flat with their feet elevated. The patient's blood pressure was also taken and their blood pressure was 109/81 with a pulse rate of 49. After five minutes the patient reported feeling a little better. Another five minutes later the patient reported significant improvement and was able to stand and walk on his own. It was recommended the family stay in the store for another 15 minutes just to be safe. 15 minutes later the mother reported that the patient felt much better. The family was called four hours later to be safe and they reported no problems.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ lot # L048854, expiration date 31-AUG-2017, lot # reported as L035637, expiration date 09-JUN-2017, lot # M007124, expiration date 05-OCT-2017, lot # M019708, expiration date 25-OCT-2017 (exact dose was not reported, orally). There was no adverse effect reported. These doses of ROTATEQ were exposed to 51 degrees Fahrenheit for 2 hours 30 minutes, 47.9 degrees Fahrenheit for 5 hours 20 minutes, 33 degrees Fahrenheit for 6 hours 50 minutes, and 47.6 degrees Fahrenheit for 20 minutes. This is one of several reports received from the same reporter. Additional information has been requested.
hot knot in left arm at site of vaccination.  Same reaction as 1st shot.  1st shot soreness lasted 3.5 weeks.  Not bad enough to prevent  normal movement.
04/09/2021 Covid-19 Vaccine shot 04/10/2021 Wake-up I had a red oval were they injected me, Light headache (Take an acetaminophen pill), Chills all day and I started sweating at night 04/11/2021 Very Light headache (Take an acetaminophen pill), light chills
THE PATIENT RECEIVED 0.25mL  OF THE MODERNA BIVALENT VACCINE.
Feb. 12, 2021 6:30 am headache-headache pills Feb. 14, 2021 Headache-headache pills Feb15, 2021 Headache, chills-headache pills All above symptoms went away within 15 to 20 mins.
Two patients both had reactions to the flu shot.  both within 30 seconds to a minute.  First patient muscles tensed up . she fell of the chair, and she passed out for a few seconds.  Then , second patient also started to feel faint.  911 was called.  Both girls were sweaty and needed to remove her mask.  First patient stayed on the floor with her dada holding her.  Second patient remained in the chair.  First patient was up and talking within a few seconds, but quickly began to become sleepy and started slurring her words.  Paramedics arrived on the scene and transported both girls to the hospital.
Pain when moving, no swelling or rash but feel like the whole right arm as charley horse. the pain radiates from injection site and slowly goes down.
Fatigue, lightheaded ness, dizziness, nausea, chills, sweats, fever remaining 3 weeks after vaccine
Xerostomia and epiphora 12 hours post vaccination; left eye irritation and muscle spasm of neck 24 hours post vaccination; loss of vision to left eye 7 days post vaccination; post ER physician presciption education to patient Bell's Palsy - acetaminophen-codeine, acyclovir, codeine phosphate oral tablet, medrol dose pack.
localized rxn to DTAP 3.5 x 5cm red area rt thigh, warm to touch;
Child dvlped cellulitis in lt thigh(17 cm x 18 cm area of redness) after recv'g DTAP & Hib vax. Hospitalized for IV antibiotics. Discharge summary indicates felt that pt had a cellutlitis but more likely an allergic reaction as well. He received IV Solu-Medrol, IV oxacillin, and oral and IV Benadryl.
Pt had his pharmacist call while he was there to pick up rx pt said he was experiencing SOB 45 minutes, after he received the PREVANR 13 vx, Dr was gone so dr advised pt to go to the ER for help.
12/28/21 presents to Diagnostic Radiology for "elective kidney biopsy, ordered by his transplant surgeon". PMHx of "HTN, CAD, AV replacement, DVT, ESRD s/p renal transplant x 2"